Strategic Advisory Board for Intellectual Property Policy

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023
Fashion, Online Retail, Retail, Sports, Other Retail, Other Sports, Adjustment, NFL, Strategic Advisory Board for Intellectual Property Policy, Aka, NYSE, NBA, Ness, EBITDA, G&A, GAAP, Mitchell & Ness, Athlete, Petal, McLaren, Mitchell, Growth, Partnership, Webcast, Culture Kings, Interim, Westfield Century City, Forecasting, Formula, Marketing, Video game, Online shopping, Bank, Target

Brands Holding Corp. (NYSE: AKA), a brand accelerator of next generation fashion brands, today announced financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Brands Holding Corp. (NYSE: AKA), a brand accelerator of next generation fashion brands, today announced financial results for the third quarter ended September 30, 2023.
  • A conference call to discuss the Company’s third quarter results is scheduled for November 8, 2023, at 4:30 p.m.
  • The non-GAAP financial measures should not be considered in isolation or as a substitute for the GAAP financial measures.
  • The non-GAAP financial measures used by the Company may be different from similarly-titled non-GAAP financial measures used by other companies.

The Garrett Companies Nets 167% Completed Development Increase in 2023

Retrieved on: 
Thursday, October 26, 2023
Woman, Real estate, Central Waqf Council, Indianapolis Business Journal, Denver Technological Center, The Denver Post, Workplace, Growth, Strategic Advisory Board for Intellectual Property Policy, The Best Place to Be, The Indianapolis Star, HVAC, Culture, Commercial property, Nursing, Management

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ -- The Garrett Companies, a full-service real estate company specializing in multifamily investments, development, construction and asset management, has announced a 167% increase in completed developments in 2023 compared to 2022, alongside several award wins and growth milestones.

Key Points: 
  • In 2023 alone, The Garrett Companies completed eight projects across five states and has 27 active construction projects currently in operation — an increase of nearly 13% year over year.
  • The Garrett Companies expanded its portfolio in 2023 with several new initiatives, including the creation of a Strategic Advisory Board to enhance its scaling operations.
  • This is The Garrett Companies' eighth consecutive year earning this recognition, a feat that less than 1% of companies have accomplished.
  • "I started The Garrett Companies to create a company and culture conducive to collaboration, growth and innovation," said Eric Garrett , CEO of The Garrett Companies.

The Beryl Institute Announces 7 New Strategic Advisory Board Members

Retrieved on: 
Wednesday, September 13, 2023
LCSW, Central Waqf Council, Strategic Advisory Group of Experts, UCLA School of Nursing, Doctor of Philosophy, Strategic Advisory Board for Intellectual Property Policy, UCLA Health, Patient, Veterans' affairs, Nursing, Growth, Management

NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board. The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute. The board provides practical advice on strategy, growth opportunities and future plans, along with valuable insights into market and industry trends.

Key Points: 
  • NASHVILLE, Tenn. , Sept. 13, 2023 /PRNewswire-PRWeb/ -- Strengthening its dedication to the growth of the patient experience across the continuum of care, The Beryl Institute welcomes new members to its Strategic Advisory Board .
  • The Strategic Advisory Board serve as a key advisor to operations of The Beryl Institute.
  • Joining the previous 11 members, new members of the Strategic Advisory Board include:
    Karen Grimley, PhD, Chief Nursing Executive and Assistant Dean, UCLA Health and UCLA School of Nursing
    -Jennifer Purdy, LCSW, CPXP, Executive Director, CX Tools and Implementation Veterans Experience Office, Dept.
  • of Veterans Affairs
    "We are honored to engage these new members and the diversity of voices they represent - from patients, professionals and executives around the world - to our Strategic Advisory Board," said Jason Wolf, Ph.D., CPXP, President and CEO of The Beryl Institute.

Trivest Partners Acquires ABC-Amega

Retrieved on: 
Tuesday, August 15, 2023
Professional Services, Payments, Technology, Finance, Personal Finance, Accounting, Culture, Partner, Acquisition, Collection, ABC, BII, Strategic Advisory Board for Intellectual Property Policy, Bank, Trivest

Trivest Partners (“Trivest”) is pleased to announce it has acquired ABC-Amega, Inc. (“ABC-Amega”).

Key Points: 
  • Trivest Partners (“Trivest”) is pleased to announce it has acquired ABC-Amega, Inc. (“ABC-Amega”).
  • It has evolved over the years to become one of the most trusted full-service, B2B accounts receivable management and industry credit services providers.
  • The ABC-Amega acquisition expands the capabilities of BII Services Corp (“BII”), a holding company formed by Trivest to build the premier provider of commercial order-to-cash management solutions.
  • “I first met the team from Trivest in early 2023 to discuss our respective views on the future of the commercial collection industry,” said David Herer.

Simmons University Institute for Inclusive Leadership Welcomes New Executive Board Members from Boston Children's Hospital, Point32Health, RTX, and St. Jude Children's Research Hospital

Retrieved on: 
Thursday, August 17, 2023
Workforce, Human resources, Pratt & Whitney, Simmons University, Partnership, Boston Children's Chorus, Central Waqf Council, International Coaching Federation, RAINN, Gender, Culture, Faith, Boston Children's Hospital, Health equity, St. Jude Children's Research Hospital, Woman, Public policy, Research, Human, Mother, Strategic Advisory Board for Intellectual Property Policy, DE, Shanda, Parity, Social justice, Patient, St. Peter Church (Cleveland, Ohio), Faculty, Inclusion, DEI, Hospital, Collins Aerospace, MPH, Faith and Politics Institute, RTX, Management, Nursing, Jude the Apostle, MD

"I am honored to welcome these four incredible, mission-driven leaders to the Strategic Advisory Board," said Susan MacKenty Brady, CEO of the Institute for Inclusive Leadership.

Key Points: 
  • "I am honored to welcome these four incredible, mission-driven leaders to the Strategic Advisory Board," said Susan MacKenty Brady, CEO of the Institute for Inclusive Leadership.
  • "They each bring a diverse set of skills and expertise and share a deep desire to foster equity, inclusion, and gender parity in organizational leadership.
  • "I am so thrilled that we are able to welcome these four leaders to the Strategic Advisory Board," said Simmons University President Lynn Perry Wooten.
  • She provides leadership, vision and strategic oversight for the Boston Children's Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion.

Keurig Dr Pepper Names Interim Chief Corporate Affairs Officer

Retrieved on: 
Friday, August 4, 2023
Interim, Partnership, University, Senior, Strategic Advisory Board for Intellectual Property Policy, KDP, Business, Ecology, MBA, Ford Motor Company, ELT, World Coffee Research, University of Michigan School for Environment and Sustainability, Retirement, Miami University, Sustainability, School, Ross School of Business, Environment, Ross School, Management, Biology

and FRISCO, Texas, Aug. 4, 2023 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today announced the appointment of Monique Oxender as Interim Chief Corporate Affairs Officer, reporting to Chairman & CEO Bob Gamgort and joining the Executive Leadership Team (ELT).

Key Points: 
  • and FRISCO, Texas, Aug. 4, 2023 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today announced the appointment of Monique Oxender as Interim Chief Corporate Affairs Officer, reporting to Chairman & CEO Bob Gamgort and joining the Executive Leadership Team (ELT).
  • In this role, Oxender will oversee the Company's corporate responsibility, government affairs, corporate communications and internal communications work.
  • Oxender has been with KDP for more than 11 years, most recently as Senior Vice President & Chief Sustainability Officer, where she designed the organizational and strategic framework for the Company's ambitious corporate responsibility platform.
  • I'm excited to collaborate with her and our executive leadership teams on further enhancing our corporate reputation and sharing our growth story."

Akari Therapeutics Appoints Industry Veteran Wa’el Hashad to Board of Directors

Retrieved on: 
Wednesday, July 5, 2023
Amgen, Boehringer, University, Central Waqf Council, Marketing, Audit committee, Medication, Geographic atrophy, Metabolic disorder, David Berry (inventor), Washington State University College of Pharmacy and Pharmaceutical Sciences, Eli Lilly, Strategic Advisory Board for Intellectual Property Policy, Boehringer Ingelheim, Neuroscience, Plasma protein binding, International business, Otsuka Pharmaceutical, Akari, Eli Lilly and Company, Therapy, American University in Cairo, Pharmaceutical industry, Pharmacy

NEW YORK and LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of industry veteran Wa’el Hashad to the Akari Board of Directors as an independent director.

Key Points: 
  • NEW YORK and LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of industry veteran Wa’el Hashad to the Akari Board of Directors as an independent director.
  • “I am pleased to welcome Wa’el to our Board of Directors” said Ray Prudo, M.D., Akari Chairman.
  • Avanir was acquired by Otsuka Pharmaceutical, and Mr. Hashad led the company’s full integration into Otsuka’s United States operations.
  • He held the position of the Chairman of the Strategic Advisory Board at Morningside Biopharma and is currently a member of the Board of California Life Sciences.

Crush Capital Forms Strategic Advisory Board; Appoints Serial-Entrepreneur Josh Snow as Advisor

Retrieved on: 
Tuesday, June 20, 2023
Central Waqf Council, Life, Going public, CPG, Dow Jones, Mentorship, Growth, LOS, Strategic Advisory Board for Intellectual Property Policy, Management, Season

LOS ANGELES, CA, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Crush Capital Inc., the creators of the first Click-to-Invest streaming series, Going Public, today announced the formation of a Strategic Advisory Board (the “Board”) and the appointment of Josh Snow as its first advisor. The Board will be comprised of experienced professionals and entrepreneurs across a wide range of industries including finance, CPG, media, and technology, and will serve to help featured companies raise capital by elevating their strategy and story. 

Key Points: 
  • The new Advisory Board will support the growth of the Going Public series and the companies it features by providing founders with strategic guidance on storytelling, capital formation, and business strategy.
  • LOS ANGELES, CA, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Crush Capital Inc. , the creators of the first Click-to-Invest streaming series, Going Public, today announced the formation of a Strategic Advisory Board (the “Board”) and the appointment of Josh Snow as its first advisor.
  • “As both a featured Mentor in Season 1 and strategic investor in Crush Capital, Josh is intimately familiar with our mission to democratize private capital markets,” commented Todd Goldberg, Co-CEO of Crush Capital.
  • "I’m excited to formally join the Going Public team as a Strategic Advisor.

Longeveron Welcomes Three New Prominent Board Members

Retrieved on: 
Tuesday, June 13, 2023
Bachelor of Science in Human Biology, FACC, University of Pennsylvania, MBA, City, University of London, Audible Magic, Thomas, Eli Lilly and Company, Berlin Packaging, Joseph M. Katz Graduate School of Business, University, Galena Biopharma, Carnegie Mellon University, Regenerative medicine, Boehringer Ingelheim, UCB, Magic, Book, Biotechnology, S.A, Wharton School of the University of Pennsylvania, Cranfield School of Management, Amgen, PCSA, Girolamo, San Francisco Playhouse, Portable ultrasound, Organizational behavior, SONO, Postgraduate education, WSTM, Aerospace engineering, American University in Cairo, Strategic Advisory Board for Intellectual Property Policy, Management, MD, Shareholder, Stanford University

MIAMI, June 13, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today the election of three distinguished new directors to serve on the Longeveron Inc. Board of Directors. Wa’el Hashad, Khoso Baluch, and Jeffrey Pfeffer were elected at the Company’s Annual Meeting of Stockholders, held Friday June 9, 2023, and will serve until the 2026 Annual Meeting of Stockholders, or until their successors are duly elected. Concurrent with the election of the new Directors, the terms of Donald Soffer, Erin Borger, and Todd Girolamo to serve as directors expired.

Key Points: 
  • “We are very honored to welcome such prominent and experienced new members to our Board and look forward to their tremendous expertise, diverse experience, and counsel as we continue to advance our regenerative medicine toward critical milestones,” said Joshua M. Hare, MD, FACC, and Chairman of Longeveron.
  • We believe Longeveron is well positioned to realize the potential of Lomecel-B™, and we thank them for their dedication and service,” concluded Dr. Hare.
  • Summary biographies of the new directors are as follows:
    Wa’el Hashad has served as Chief Executive Officer of Longeveron since February, 2023.
  • He served as the Chairman of the Board for Da Volterra, a French privately held company, from December 2021 until November 2022.

Vesey Street Capital Partners Strengthens its Team by Announcing the Addition of Heyward Donigan and Debbie Osteen to its Strategic Advisory Board

Retrieved on: 
Thursday, May 25, 2023
SAB, Kindred Healthcare, Acadia Healthcare, Beacon Health Options, Central Waqf Council, VSCP, General Electric, University, Modern Healthcare, Culture, Rite Aid, Workplace, Health care, Universal Health Services, Premera Blue Cross, Master of Public Administration, Woman, Human, Cigna, Female, Organization, P&L, Hospital, Health, Investment, Strategic Advisory Board for Intellectual Property Policy, Healthcare in the United States, Growth, Osteen, Management, Marie Donigan, New York University, U.K

As such, we are adding two executives to our strategic advisory board who bring a wealth of industry expertise and success in leading Healthcare Services businesses.

Key Points: 
  • As such, we are adding two executives to our strategic advisory board who bring a wealth of industry expertise and success in leading Healthcare Services businesses.
  • "I am excited to become a part of VSCP's Strategic Advisory Board," noted Heyward.
  • "Joining this Strategic Advisory Board is a privilege, and I am excited about the potential to help shape the future of healthcare services", says Osteen.
  • Heyward Donigan was most recently the chief executive officer of Rite Aid, a position she was appointed to in August 2019.